Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neuroone Medical Technologies (NMTC) Liabilities and Shareholders Equity (2016 - 2025)

Historic Liabilities and Shareholders Equity for Neuroone Medical Technologies (NMTC) over the last 14 years, with Q4 2025 value amounting to $8.6 million.

  • Neuroone Medical Technologies' Liabilities and Shareholders Equity rose 3207.59% to $8.6 million in Q4 2025 from the same period last year, while for Dec 2025 it was $34.6 million, marking a year-over-year increase of 5623.13%. This contributed to the annual value of $10.8 million for FY2025, which is 10085.23% up from last year.
  • Neuroone Medical Technologies' Liabilities and Shareholders Equity amounted to $8.6 million in Q4 2025, which was up 3207.59% from $10.8 million recorded in Q3 2025.
  • In the past 5 years, Neuroone Medical Technologies' Liabilities and Shareholders Equity ranged from a high of $17.2 million in Q4 2021 and a low of $4.5 million during Q1 2025
  • For the 5-year period, Neuroone Medical Technologies' Liabilities and Shareholders Equity averaged around $8.9 million, with its median value being $8.3 million (2023).
  • As far as peak fluctuations go, Neuroone Medical Technologies' Liabilities and Shareholders Equity crashed by 5023.55% in 2023, and later surged by 12023.95% in 2025.
  • Quarter analysis of 5 years shows Neuroone Medical Technologies' Liabilities and Shareholders Equity stood at $17.2 million in 2021, then tumbled by 43.78% to $9.7 million in 2022, then tumbled by 39.73% to $5.8 million in 2023, then rose by 11.54% to $6.5 million in 2024, then skyrocketed by 32.08% to $8.6 million in 2025.
  • Its Liabilities and Shareholders Equity was $8.6 million in Q4 2025, compared to $10.8 million in Q3 2025 and $10.8 million in Q2 2025.